NIMU Reports Zero Revenue, $30K Loss Amidst Preferred Stock Issuance

TL;DR

NIMU is a pre-revenue penny stock burning cash, avoid unless you're a high-risk speculator betting on a future product.

AI Summary

NON INVASIVE MONITORING SYSTEMS INC (NIMU) reported no revenue for the three and nine months ended April 30, 2025, consistent with the prior year periods. The company incurred net losses of $10,000 for the three months ended April 30, 2025, and $30,000 for the nine months ended April 30, 2025, which are unchanged from the corresponding periods in 2024. Key business changes include the issuance of 10,000,000 shares of Series B Preferred Stock for $10,000 during the nine months ended April 30, 2025, a significant event as the company previously had no preferred stock. The company also issued 10,000,000 shares of common stock for $10,000 during the same period. A primary risk highlighted is the company's reliance on related party financing, with $10,000 in notes payable to a related party as of April 30, 2025. The strategic outlook remains unclear given the lack of revenue and ongoing losses, indicating a pre-revenue or early-stage operational phase focused on capital raising.

Why It Matters

For investors, NIMU's continued lack of revenue and reliance on related party financing signals a highly speculative investment, with no clear path to profitability or market competitiveness in the electromedical and electrotherapeutic apparatus sector. Employees face uncertainty given the company's pre-revenue status and minimal operational activity. Customers are not directly impacted as there are no products or services generating revenue. The broader market sees NIMU as a micro-cap entity with negligible impact, but its financial structure highlights the risks associated with early-stage, thinly traded companies, especially when compared to established players in the medical device industry.

Risk Assessment

Risk Level: high — The risk level is high due to zero revenue for the three and nine months ended April 30, 2025, and consistent net losses of $10,000 and $30,000 respectively. Furthermore, the company's reliance on related party financing, evidenced by $10,000 in notes payable to a related party, indicates a lack of independent funding sources and significant financial vulnerability.

Analyst Insight

Investors should exercise extreme caution and likely avoid NIMU given its pre-revenue status, consistent losses, and reliance on related party financing. This stock is suitable only for highly speculative investors comfortable with significant capital loss risk, and even then, thorough due diligence on any potential future product or business plan is essential.

Financial Highlights

debt To Equity

N/A

revenue

$0

operating Margin

N/A

total Assets

N/A

total Debt

N/A

net Income

-$30,000

eps

N/A

gross Margin

N/A

cash Position

N/A

revenue Growth

0.0%

Revenue Breakdown

Key Numbers

• $0 — Revenue (for three and nine months ended April 30, 2025, indicating pre-revenue status)
• -$10,000 — Net Loss (for three months ended April 30, 2025, unchanged from prior year)
• -$30,000 — Net Loss (for nine months ended April 30, 2025, unchanged from prior year)
• 10,000,000 — Series B Preferred Stock Shares Issued (for $10,000 during the nine months ended April 30, 2025)
• 10,000,000 — Common Stock Shares Issued (for $10,000 during the nine months ended April 30, 2025)
• $10,000 — Notes Payable to Related Party (as of April 30, 2025, highlighting financing reliance)

Key Players & Entities

• NON INVASIVE MONITORING SYSTEMS INC (company) — filer of the 10-Q
• NIMU (company) — ticker symbol
• $10,000 (dollar_amount) — net loss for three months ended April 30, 2025
• $30,000 (dollar_amount) — net loss for nine months ended April 30, 2025
• 10,000,000 (dollar_amount) — shares of Series B Preferred Stock issued
• Series B Preferred Stock (company) — newly issued equity
• April 30, 2025 (date) — end of reporting period
• Related Party (person) — source of notes payable
• 10,000,000 (dollar_amount) — shares of common stock issued

FAQ

Risk Factors

• Reliance on Related Party Financing [medium — financial]: The company has $10,000 in notes payable to a related party as of April 30, 2025. This reliance on related party financing indicates a potential vulnerability if such financing is withdrawn or becomes unfavorable.
• Pre-Revenue Stage and Lack of Operating History [high — operational]: The company reported no revenue for the nine months ended April 30, 2025. This pre-revenue status, coupled with ongoing net losses, suggests significant execution risk and uncertainty regarding the company's ability to generate sustainable income.
• Ongoing Net Losses [medium — financial]: The company incurred net losses of $10,000 for the three months and $30,000 for the nine months ended April 30, 2025. These losses, while unchanged from the prior year, highlight the absence of profitability and the need for continued funding.

Industry Context

NON INVASIVE MONITORING SYSTEMS INC operates within the electromedical and electrotherapeutic apparatus sector. This industry is characterized by rapid technological advancements, significant R&D investment, and stringent regulatory oversight from bodies like the FDA. Companies in this space often focus on developing innovative diagnostic and monitoring devices for healthcare applications.

Regulatory Implications

As a company in the medical device sector, NIMU is subject to rigorous regulatory scrutiny, particularly from the FDA, for product approval and safety. Compliance with evolving healthcare regulations and data privacy laws (like HIPAA) is critical for market access and operational viability.

What Investors Should Do

1. Monitor future capital raises and financing sources.
2. Evaluate the company's product development progress and market strategy.
3. Assess the valuation implications of recent share issuances.

Key Dates

• 2025-04-30: Quarter End and Nine Months End — Reporting period for the 10-Q, showing $0 revenue and net losses of $10,000 (QTD) and $30,000 (YTD).
• 2025-06-13: 10-Q Filing Date — The company officially filed its quarterly report, providing updated financial information and business disclosures.
• 1989-11-16: Name Change to NON INVASIVE MONITORING SYSTEMS INC — Indicates a historical change in the company's identity from BIRDFINDER CORP.

Glossary

Series B Preferred Stock

A class of stock that has certain rights and privileges over common stock, often including liquidation preferences or dividend rights. It is a form of equity financing. (The company issued 10,000,000 shares of Series B Preferred Stock for $10,000 during the nine months ended April 30, 2025, marking its first issuance of preferred stock.)

Notes Payable to Related Party

Money owed by the company to individuals or entities that have a close relationship with the company, such as major shareholders or management. (The company has $10,000 in such debt as of April 30, 2025, highlighting a key financing risk.)

Pre-revenue

A stage of a company's lifecycle where it has not yet generated any sales revenue, typically focusing on product development, research, or market entry. (The company's reported $0 revenue indicates it is in a pre-revenue stage.)

Year-Over-Year Comparison

For the nine months ended April 30, 2025, NON INVASIVE MONITORING SYSTEMS INC reported $0 in revenue, consistent with the same period in the prior year. Net losses also remained unchanged at $30,000 year-over-year. A significant development is the issuance of 10,000,000 shares of Series B Preferred Stock and 10,000,000 shares of common stock for $10,000 each during the current period, indicating a shift in capital structure and potential dilution. The reliance on related party financing, evidenced by $10,000 in notes payable, persists.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on June 13, 2025 by Related Party regarding NON INVASIVE MONITORING SYSTEMS INC /FL/ (NIMU).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR